In a new job - August 1, 2023
AstraZeneca appoints EVP BioPharmaceuticals R&D
AstraZeneca has announced the appointment of Sharon Barr as Executive Vice President, BioPharmaceuticals R&D. Sharon Barr will be responsible for discovery through to late-stage development across Cardiovascular, Renal & Metabolism and Respiratory & Immunology. She will report to Chief Executive Officer, Pascal Soriot and become a member of AstraZeneca’s Senior Executive Team (SET) as of […]
In a new job - July 28, 2023
TATAA appoints Scientific Officer and Head of Bioinformatics
TATAA Biocenter has announced the promotion of Sofia Adolfsson to Head of Bioinformatics and Scientific Officer. In her new role, Sofia Adolfsson will support the company’s leadership team in its continued growth and long-term ambitions. She will spearhead the advancement of TATAA’s offerings in the realm of precision medicine, define strategic objectives and execute the […]
In a new job - July 14, 2023
Recipharm appoints President of its biologics business unit
Recipharm has announced the appointment of Vikas Gupta as President of its recently renamed biologics business unit, ReciBioPharm. This appointment comes as Recipharm officially renames its biologics business unit following the acquisitions of advanced therapy CDMO, Arranta Bio; GenIbet, a specialist in the manufacture of biological clinical material; and virotherapy CDMO, Vibalogics. “Vikas has a […]
In a new job - June 29, 2023
Deborah Dunsire has chosen to retire from Lundbeck
Lundbeck has announced that the Board of Directors has initiated CEO succession. Deborah Dunsire has chosen to retire from Lundbeck. The Board of Directors has appointed Charl van Zyl as new President and CEO of Lundbeck. Deborah Dunsire will continue to serve as President and CEO until Charl van Zyl assumes the position no later […]
In a new job - June 7, 2023
XNK Therapeutics appoints Chief Financial Officer
XNK Therapeutics has announced the appointment of Hugo Petit as Chief Financial Officer (CFO) and member of the company’s leadership team. “We are very pleased to have Hugo join us as XNK’s new CFO. His wealth of financial experience, particularly in the life sciences sector, will strengthen the organization as we continue to grow the […]
In a new job - June 6, 2023
Devyser’s Deputy CEO and founder will leave his position
Devyser’s Deputy CEO and founder Ulf Klangby will leave his position within the company for an advisory role as a consultant as of July 1, 2023. Ulf Klangby will leave his operational role as part of the group management team and instead support the company as a consultant. In his consulting role, Ulf will support […]
